{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T14:33:23Z","timestamp":1791470003169,"version":"4.3.4"},"publisher-location":"Cham","reference-count":106,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030304010","type":"print"},{"value":"9783030304027","type":"electronic"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/978-3-030-30402-7_5","type":"book-chapter","created":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T08:04:26Z","timestamp":1580457866000},"page":"143-162","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Maternal Prenatal Exposures in Pregnancy and Autism Spectrum Disorder: An Insight into the Epigenetics of Drugs and Diet as Key Environmental Influences"],"prefix":"10.1007","author":[{"given":"Kholoud N.","family":"Bastaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sura","family":"Alwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farah R.","family":"Zahir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,1]]},"reference":[{"key":"5_CR1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders (DSM-5\u00ae)","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (DSM-5\u00ae). Washington, DC: Author."},{"key":"5_CR2","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.brainresbull.2016.04.015","volume":"125","author":"JR Homberg","year":"2016","unstructured":"Homberg, J. R., Kyzar, E. J., Scattoni, M. L., Norton, W. H., Pittman, J., Gaikwad, S., et al. (2016). Genetic and environmental modulation of neurodevelopmental disorders: Translational insights from labs to beds. Brain Research Bulletin, 125, 79\u201391.","journal-title":"Brain Research Bulletin"},{"key":"5_CR3","doi-asserted-by":"publisher","first-page":"82","DOI":"10.11604\/pamj.2016.25.82.4151","volume":"25","author":"DM Mpaka","year":"2016","unstructured":"Mpaka, D. M., Okitundu, D. L. E. A., Ndjukendi, A. O., N\u2019situ, A. M., Kinsala, S. Y., Mukau, J. E., et al. (2016). Prevalence and comorbidities of autism among children referred to the outpatient clinics for neurodevelopmental disorders. The Pan African Medical Journal, 25, 82\u201382.","journal-title":"The Pan African Medical Journal"},{"key":"5_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrg3999","volume":"17","author":"LELM Vissers","year":"2015","unstructured":"Vissers, L. E. L. M., Gilissen, C., & Veltman, J. A. (2015). Genetic studies in intellectual disability and related disorders. Nature Reviews Genetics, 17, 9.","journal-title":"Nature Reviews Genetics"},{"key":"5_CR5","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1542\/peds.2010-2989","volume":"127","author":"CA Boyle","year":"2011","unstructured":"Boyle, C. A., Boulet, S., Schieve, L. A., Cohen, R. A., Blumberg, S. J., Yeargin-Allsopp, M., et al. (2011). Trends in the prevalence of developmental disabilities in US Children, 1997\u20132008. Pediatrics, 127, 1034\u20131042.","journal-title":"Pediatrics"},{"key":"5_CR6","unstructured":"Gupta, S., Venkatesan, S. P., Goswami, S., & Kumar, R. (2018). Emerging trends in the diagnosis and intervention of neurodevelopmental disorders. IGI Global."},{"key":"5_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss6503a1","volume":"65","author":"DL Christensen","year":"2016","unstructured":"Christensen, D. L., Baio, J., Van Naarden Braun, K., Bilder, D., Charles, J., Constantino, J. N., et al. (2016). Prevalence and characteristics of autism spectrum disorder among children aged 8 Years--Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2012. MMWR Surveillance Summaries, 65, 1\u201323.","journal-title":"MMWR Surveillance Summaries"},{"key":"5_CR8","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/aur.239","volume":"5","author":"M Elsabbagh","year":"2012","unstructured":"Elsabbagh, M., Divan, G., Koh, Y.-J., Kim, Y. S., Kauchali, S., Marc\u00edn, C., et al. (2012). Global prevalence of autism and other pervasive developmental disorders. Autism Research: Official Journal of the International Society for Autism Research, 5, 160\u2013179.","journal-title":"Autism Research: Official Journal of the International Society for Autism Research"},{"key":"5_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.mm6701a1","volume":"67","author":"J Baio","year":"2018","unstructured":"Baio, J., Wiggins, L., Christensen, D. L., Maenner, M. J., Daniels, J., Warren, Z., et al. (2018). Prevalence of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 Sites, United States, 2014. Morbidity and Mortality Weekly Report. Surveillance Summaries (Washington, D.C. : 2002), 67, 1\u201323.","journal-title":"Morbidity and Mortality Weekly Report. Surveillance Summaries (Washington, D.C. : 2002)"},{"key":"5_CR10","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1001\/jama.2017.17812","volume":"319","author":"G Xu","year":"2018","unstructured":"Xu, G., Strathearn, L., Liu, B., & Bao, W. (2018). Prevalence of autism spectrum disorder among us children and adolescents, 2014\u20132016. JAMA, 319, 81\u201382.","journal-title":"JAMA"},{"key":"5_CR11","doi-asserted-by":"publisher","first-page":"910946","DOI":"10.1155\/2012\/910946","volume":"2012","author":"SD Bilbo","year":"2012","unstructured":"Bilbo, S. D., Jones, J. P., & Parker, W. (2012). Is autism a member of a family of diseases resulting from genetic\/cultural mismatches? Implications for treatment and prevention. Autism Research and Treatment, 2012, 910946.","journal-title":"Autism Research and Treatment"},{"key":"5_CR12","doi-asserted-by":"publisher","first-page":"26253","DOI":"10.3402\/mehd.v26.26253","volume":"26","author":"SD Bilbo","year":"2015","unstructured":"Bilbo, S. D., Nevison, C. D., & Parker, W. (2015). A model for the induction of autism in the ecosystem of the human body: The anatomy of a modern pandemic? Microbial Ecology in Health and Disease, 26, 26253.","journal-title":"Microbial Ecology in Health and Disease"},{"key":"5_CR13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1136\/bmj.317.7151.111","volume":"317","author":"WJ Meerding","year":"1998","unstructured":"Meerding, W. J., Bonneux, L., Polder, J. J., Koopmanschap, M. A., & Van Der Maas, P. J. (1998). Demographic and epidemiological determinants of healthcare costs in Netherlands: Cost of illness study. BMJ (Clinical research ed.), 317, 111\u2013115.","journal-title":"BMJ (Clinical research ed.)"},{"key":"5_CR14","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.psc.2009.12.002","volume":"33","author":"P El-Fishawy","year":"2010","unstructured":"El-Fishawy, P., & State, M. W. (2010). The genetics of autism: Key issues, recent findings, and clinical implications. The Psychiatric Clinics of North America, 33, 83\u2013105.","journal-title":"The Psychiatric Clinics of North America"},{"key":"5_CR15","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.tics.2011.07.003","volume":"15","author":"DH Geschwind","year":"2011","unstructured":"Geschwind, D. H. (2011). Genetics of autism spectrum disorders. Trends in Cognitive Sciences, 15, 409\u2013416.","journal-title":"Trends in Cognitive Sciences"},{"key":"5_CR16","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1002\/aur.1938","volume":"11","author":"I Hertz-Picciotto","year":"2018","unstructured":"Hertz-Picciotto, I., Schmidt, R. J., & Krakowiak, P. (2018). Understanding environmental contributions to autism: Causal concepts and the state of science. Autism Research, 11, 554\u2013586.","journal-title":"Autism Research"},{"key":"5_CR17","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1093\/ije\/dyt282","volume":"43","author":"K Lyall","year":"2014","unstructured":"Lyall, K., Schmidt, R. J., & Hertz-Picciotto, I. (2014). Maternal lifestyle and environmental risk factors for autism spectrum disorders. International Journal of Epidemiology, 43, 443\u2013464.","journal-title":"International Journal of Epidemiology"},{"key":"5_CR18","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2217\/epi.15.92","volume":"8","author":"DR Grayson","year":"2016","unstructured":"Grayson, D. R., & Guidotti, A. (2016). Merging data from genetic and epigenetic approaches to better understand autistic spectrum disorder. Epigenomics, 8, 85\u2013104.","journal-title":"Epigenomics"},{"key":"5_CR19","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3389\/fneur.2015.00107","volume":"6","author":"YJ Loke","year":"2015","unstructured":"Loke, Y. J., Hannan, A. J., & Craig, J. M. (2015). The role of epigenetic change in autism spectrum disorders. Frontiers in Neurology, 6, 107.","journal-title":"Frontiers in Neurology"},{"key":"5_CR20","doi-asserted-by":"publisher","first-page":"92R","DOI":"10.1203\/PDR.0b013e318213565e","volume":"69","author":"FR Zahir","year":"2011","unstructured":"Zahir, F. R., & Brown, C. J. (2011). Epigenetic impacts on neurodevelopment: Pathophysiological mechanisms and genetic modes of action. Pediatric Research, 69, 92R.","journal-title":"Pediatric Research"},{"key":"5_CR21","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.cell.2014.06.017","volume":"158","author":"R Bernier","year":"2014","unstructured":"Bernier, R., Golzio, C., Xiong, B., Stessman, H. A., Coe, B. P., Penn, O., et al. (2014). Disruptive CHD8 mutations define a subtype of autism early in development. Cell, 158, 263\u2013276.","journal-title":"Cell"},{"key":"5_CR22","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/nature10989","volume":"485","author":"BJ O\u2019Roak","year":"2012","unstructured":"O\u2019Roak, B. J., Vives, L., Girirajan, S., Karakoc, E., Krumm, N., Coe, B. P., et al. (2012). Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature, 485, 246\u2013250.","journal-title":"Nature"},{"key":"5_CR23","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.1002\/ajmg.a.37669","volume":"170","author":"FR Zahir","year":"2016","unstructured":"Zahir, F. R., Tucker, T., Mayo, S., Brown, C. J., Lim, E. L., Taylor, J., et al. (2016). Intragenic CNVs for epigenetic regulatory genes in intellectual disability: Survey identifies pathogenic and benign single exon changes. American Journal of Medical Genetics. Part A, 170, 2916\u20132926.","journal-title":"American Journal of Medical Genetics. Part A"},{"key":"5_CR24","doi-asserted-by":"publisher","first-page":"dvv012","DOI":"10.1093\/eep\/dvv012","volume":"2","author":"KP Keil","year":"2016","unstructured":"Keil, K. P., & Lein, P. J. (2016). DNA methylation: A mechanism linking environmental chemical exposures to risk of autism spectrum disorders? Environmental Epigenetics, 2, dvv012.","journal-title":"Environmental Epigenetics"},{"key":"5_CR25","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1080\/01677063.2016.1202951","volume":"30","author":"M Elagoz Yuksel","year":"2016","unstructured":"Elagoz Yuksel, M., Yuceturk, B., Karatas, O. F., Ozen, M., & Dogangun, B. (2016). The altered promoter methylation of oxytocin receptor gene in autism. Journal of Neurogenetics, 30, 280\u2013284.","journal-title":"Journal of Neurogenetics"},{"key":"5_CR26","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3389\/fncel.2018.00078","volume":"12","author":"AA Eshraghi","year":"2018","unstructured":"Eshraghi, A. A., Liu, G., Kay, S.-I. S., Eshraghi, R. S., Mittal, J., Moshiree, B., et al. (2018). Epigenetics and autism spectrum disorder: Is there a correlation? Frontiers in Cellular Neuroscience, 12, 78\u201378.","journal-title":"Frontiers in Cellular Neuroscience"},{"key":"5_CR27","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1002\/ppul.22930","volume":"49","author":"LP Gunawardhana","year":"2014","unstructured":"Gunawardhana, L. P., Baines, K. J., Mattes, J., Murphy, V. E., Simpson, J. L., & Gibson, P. G. (2014). Differential DNA methylation profiles of infants exposed to maternal asthma during pregnancy. Pediatric Pulmonology, 49, 852\u2013862.","journal-title":"Pediatric Pulmonology"},{"key":"5_CR28","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/mp.2013.114","volume":"19","author":"C Ladd-Acosta","year":"2014","unstructured":"Ladd-Acosta, C., Hansen, K. D., Briem, E., Fallin, M. D., Kaufmann, W. E., & Feinberg, A. P. (2014). Common DNA methylation alterations in multiple brain regions in autism. Molecular Psychiatry, 19, 862\u2013871.","journal-title":"Molecular Psychiatry"},{"key":"5_CR29","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.cell.2016.10.031","volume":"167","author":"W Sun","year":"2016","unstructured":"Sun, W., Poschmann, J., Cruz-Herrera Del Rosario, R., Parikshak, N. N., Hajan, H. S., Kumar, V., et al. (2016). Histone acetylome-wide association study of autism spectrum disorder. Cell, 167, 1385\u20131397.e11.","journal-title":"Cell"},{"key":"5_CR30","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1038\/nn.4373","volume":"19","author":"YE Wu","year":"2016","unstructured":"Wu, Y. E., Parikshak, N. N., Belgard, T. G., & Geschwind, D. H. (2016). Genome-wide, integrative analysis implicates microRNA dysregulation in autism spectrum disorder. Nature Neuroscience, 19, 1463\u20131476.","journal-title":"Nature Neuroscience"},{"key":"5_CR31","first-page":"665","volume":"63","author":"W Rosikiewicz","year":"2016","unstructured":"Rosikiewicz, W., & Makalowska, I. (2016). Biological functions of natural antisense transcripts. Acta Biochimica Polonica, 63, 665\u2013673.","journal-title":"Acta Biochimica Polonica"},{"key":"5_CR32","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13148-016-0222-5","volume":"8","author":"L Altucci","year":"2016","unstructured":"Altucci, L., & Rots, M. G. (2016). Epigenetic drugs: From chemistry via biology to medicine and back. Clinical Epigenetics, 8, 56\u201356.","journal-title":"Clinical Epigenetics"},{"key":"5_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4137\/GEG.S12270","volume":"6","author":"S Heerboth","year":"2014","unstructured":"Heerboth, S., Lapinska, K., Snyder, N., Leary, M., Rollinson, S., & Sarkar, S. (2014). Use of epigenetic drugs in disease: An overview. Genetics & Epigenetics, 6, 9\u201319.","journal-title":"Genetics & Epigenetics"},{"key":"5_CR34","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.tips.2010.08.001","volume":"31","author":"X Yang","year":"2010","unstructured":"Yang, X., Lay, F., Han, H., & Jones, P. A. (2010). Targeting DNA methylation for epigenetic therapy. Trends in Pharmacological Sciences, 31, 536\u2013546.","journal-title":"Trends in Pharmacological Sciences"},{"key":"5_CR35","first-page":"2989","volume":"33","author":"A Gnyszka","year":"2013","unstructured":"Gnyszka, A., Jastrz\u0119bski, Z., & Flis, S. (2013). DNA methyltransferase inhibitors and their emerging role in epigenetic therapy of cancer. Anticancer Research, 33, 2989\u20132996.","journal-title":"Anticancer Research"},{"key":"5_CR36","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1146\/annurev-med-111314-035900","volume":"67","author":"N Ahuja","year":"2016","unstructured":"Ahuja, N., Sharma, A. R., & Baylin, S. B. (2016). Epigenetic therapeutics: A new weapon in the war against cancer. Annual Review of Medicine, 67, 73\u201389.","journal-title":"Annual Review of Medicine"},{"key":"5_CR37","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.3390\/ijms18071414","volume":"18","author":"T Eckschlager","year":"2017","unstructured":"Eckschlager, T., Plch, J., Stiborova, M., & Hrabeta, J. (2017). Histone deacetylase inhibitors as anticancer drugs. International Journal of Molecular Sciences, 18, 1414.","journal-title":"International Journal of Molecular Sciences"},{"key":"5_CR38","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.2217\/pgs-2016-0113","volume":"17","author":"AK Goey","year":"2016","unstructured":"Goey, A. K., Sissung, T. M., Peer, C. J., & Figg, W. D. (2016). Pharmacogenomics and histone deacetylase inhibitors. Pharmacogenomics, 17, 1807\u20131815.","journal-title":"Pharmacogenomics"},{"key":"5_CR39","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.drudis.2013.11.012","volume":"19","author":"FJ Dekker","year":"2014","unstructured":"Dekker, F. J., Van Den Bosch, T., & Martin, N. I. (2014). Small molecule inhibitors of histone acetyltransferases and deacetylases are potential drugs for inflammatory diseases. Drug Discovery Today, 19, 654\u2013660.","journal-title":"Drug Discovery Today"},{"key":"5_CR40","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.2217\/epi-2016-0165","volume":"9","author":"VJ Forster","year":"2017","unstructured":"Forster, V. J., Mcdonnell, A., Theobald, R., & Mckay, J. A. (2017). Effect of methotrexate\/vitamin B(12) on DNA methylation as a potential factor in leukemia treatment-related neurotoxicity. Epigenomics, 9, 1205\u20131218.","journal-title":"Epigenomics"},{"key":"5_CR41","doi-asserted-by":"crossref","unstructured":"Williams, K., Brignell, A., Randall, M., Silove, N., & Hazell, P. (2013). Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD). Cochrane Database of Systematic Reviews, Cd004677.","DOI":"10.1002\/14651858.CD004677.pub3"},{"key":"5_CR42","first-page":"9","volume":"8","author":"M Ahmadvand","year":"2014","unstructured":"Ahmadvand, M., Noruzinia, M., Fard, A. D., Zohour, M. M., Tabatabaiefar, M. A., Soleimani, M., et al. (2014). The role of epigenetics in the induction of fetal hemoglobin: A combination therapy approach. International Journal of Hematology-Oncology and Stem Cell Research, 8, 9\u201314.","journal-title":"International Journal of Hematology-Oncology and Stem Cell Research"},{"key":"5_CR43","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/978-3-642-21631-2_11","volume":"206","author":"SS Mahajan","year":"2011","unstructured":"Mahajan, S. S., Leko, V., Simon, J. A., & Bedalov, A. (2011). Sirtuin modulators. Handbook of Experimental Pharmacology, 206, 241\u2013255.","journal-title":"Handbook of Experimental Pharmacology"},{"key":"5_CR44","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/j.1469-8749.1994.tb11856.x","volume":"36","author":"K Stromland","year":"1994","unstructured":"Stromland, K., Nordin, V., Miller, M., Akerstrom, B., & Gillberg, C. (1994). Autism in thalidomide embryopathy: A population study. Developmental Medicine and Child Neurology, 36, 351\u2013356.","journal-title":"Developmental Medicine and Child Neurology"},{"key":"5_CR45","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1001\/jama.2013.2270","volume":"309","author":"J Christensen","year":"2013","unstructured":"Christensen, J., Gr\u00f8nborg, T. K., S\u00f8rensen, M. J., Schendel, D., Parner, E. T., Pedersen, L. H., et al. (2013). Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA, 309, 1696\u20131703.","journal-title":"JAMA"},{"key":"5_CR46","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-017248","volume":"7","author":"AA Veroniki","year":"2017","unstructured":"Veroniki, A. A., Rios, P., Cogo, E., Straus, S. E., Finkelstein, Y., Kealey, R., et al. (2017). Comparative safety of antiepileptic drugs for neurological development in children exposed during pregnancy and breast feeding: A systematic review and network meta-analysis. BMJ Open, 7, e017248.","journal-title":"BMJ Open"},{"key":"5_CR47","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s11689-011-9093-4","volume":"3","author":"LA Croen","year":"2011","unstructured":"Croen, L. A., Connors, S. L., Matevia, M., Qian, Y., Newschaffer, C., & Zimmerman, A. W. (2011). Prenatal exposure to beta2-adrenergic receptor agonists and risk of autism spectrum disorders. Journal of Neurodevelopmental Disorders, 3, 307\u2013315.","journal-title":"Journal of Neurodevelopmental Disorders"},{"key":"5_CR48","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/aur.1288","volume":"6","author":"RA Harrington","year":"2013","unstructured":"Harrington, R. A., Lee, L. C., Crum, R. M., Zimmerman, A. W., & Hertz-Picciotto, I. (2013). Serotonin hypothesis of autism: Implications for selective serotonin reuptake inhibitor use during pregnancy. Autism Research, 6, 149\u2013168.","journal-title":"Autism Research"},{"key":"5_CR49","doi-asserted-by":"publisher","first-page":"e1241","DOI":"10.1542\/peds.2013-3406","volume":"133","author":"RA Harrington","year":"2014","unstructured":"Harrington, R. A., Lee, L.-C., Crum, R. M., Zimmerman, A. W., & Hertz-Picciotto, I. (2014). Prenatal SSRI use and offspring with autism spectrum disorder or developmental delay. Pediatrics, 133, e1241\u2013e1248.","journal-title":"Pediatrics"},{"key":"5_CR50","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1007\/s10803-014-2128-4","volume":"44","author":"NB Gidaya","year":"2014","unstructured":"Gidaya, N. B., Lee, B. K., Burstyn, I., Yudell, M., Mortensen, E. L., & Newschaffer, C. J. (2014). In utero exposure to selective serotonin reuptake inhibitors and risk for autism spectrum disorder. Journal of Autism and Developmental Disorders, 44, 2558\u20132567.","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"5_CR51","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1001\/jamapediatrics.2017.0124","volume":"171","author":"A Mezzacappa","year":"2017","unstructured":"Mezzacappa, A., Lasica, P. A., Gianfagna, F., Cazas, O., Hardy, P., Falissard, B., et al. (2017). Risk for autism spectrum disorders according to period of prenatal antidepressant exposure: A systematic review and meta-analysis. JAMA Pediatrics, 171, 555\u2013563.","journal-title":"JAMA Pediatrics"},{"key":"5_CR52","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12916-017-0993-3","volume":"16","author":"DR Morales","year":"2018","unstructured":"Morales, D. R., Slattery, J., Evans, S., & Kurz, X. (2018). Antidepressant use during pregnancy and risk of autism spectrum disorder and attention deficit hyperactivity disorder: Systematic review of observational studies and methodological considerations. BMC Medicine, 16, 6.","journal-title":"BMC Medicine"},{"key":"5_CR53","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.yhbeh.2018.01.003","volume":"101","author":"AZ Bauer","year":"2018","unstructured":"Bauer, A. Z., Kriebel, D., Herbert, M. R., Bornehag, C. G., & Swan, S. H. (2018). Prenatal paracetamol exposure and child neurodevelopment: A review. Hormones and Behavior, 101, 125\u2013147.","journal-title":"Hormones and Behavior"},{"key":"5_CR54","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-1316","volume":"137","author":"NB Gidaya","year":"2016","unstructured":"Gidaya, N. B., Lee, B. K., Burstyn, I., Michael, Y., Newschaffer, C. J., & Mortensen, E. L. (2016). In utero exposure to beta-2-adrenergic receptor agonist drugs and risk for autism spectrum disorders. Pediatrics, 137, e20151316.","journal-title":"Pediatrics"},{"key":"5_CR55","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0892-0362(99)00083-5","volume":"22","author":"JL Ingram","year":"2000","unstructured":"Ingram, J. L., Peckham, S. M., Tisdale, B., & Rodier, P. M. (2000). Prenatal exposure of rats to valproic acid reproduces the cerebellar anomalies associated with autism. Neurotoxicology and Teratology, 22, 319\u2013324.","journal-title":"Neurotoxicology and Teratology"},{"key":"5_CR56","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1017\/S0012162205001076","volume":"47","author":"AD Rasalam","year":"2005","unstructured":"Rasalam, A. D., Hailey, H., Williams, J. H., Moore, S. J., Turnpenny, P. D., Lloyd, D. J., et al. (2005). Characteristics of fetal anticonvulsant syndrome associated autistic disorder. Developmental Medicine and Child Neurology, 47, 551\u2013555.","journal-title":"Developmental Medicine and Child Neurology"},{"key":"5_CR57","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1212\/01.wnl.0000339399.64213.1a","volume":"71","author":"RL Bromley","year":"2008","unstructured":"Bromley, R. L., Mawer, G., Clayton-Smith, J., & Baker, G. A. (2008). Autism spectrum disorders following in utero exposure to antiepileptic drugs. Neurology, 71, 1923\u20131924.","journal-title":"Neurology"},{"key":"5_CR58","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1001\/jama.2013.2270","volume":"309","author":"J Christensen","year":"2013","unstructured":"Christensen, J., Gronborg, T. K., Sorensen, M. J., Schendel, D., Parner, E. T., Pedersen, L. H., et al. (2013). Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA, 309, 1696\u20131703.","journal-title":"JAMA"},{"key":"5_CR59","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.jaac.2010.05.005","volume":"49","author":"D Grafodatskaya","year":"2010","unstructured":"Grafodatskaya, D., Chung, B., Szatmari, P., & Weksberg, R. (2010). Autism spectrum disorders and epigenetics. Journal of the American Academy of Child and Adolescent Psychiatry, 49, 794\u2013809.","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"5_CR60","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1111\/j.1469-7610.1987.tb00677.x","volume":"28","author":"GM Anderson","year":"1987","unstructured":"Anderson, G. M., Freedman, D. X., Cohen, D. J., Volkmar, F. R., Hoder, E. L., Mcphedran, P., et al. (1987). Whole blood serotonin in autistic and normal subjects. Journal of Child Psychology and Psychiatry, 28, 885\u2013900.","journal-title":"Journal of Child Psychology and Psychiatry"},{"key":"5_CR61","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/0006-3223(88)90192-8","volume":"24","author":"EH Cook Jr","year":"1988","unstructured":"Cook Jr., E. H., Leventhal, B. L., & Freedman, D. X. (1988). Free serotonin in plasma: Autistic children and their first-degree relatives. Biological Psychiatry, 24, 488\u2013491.","journal-title":"Biological Psychiatry"},{"key":"5_CR62","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1006\/faat.1994.1098","volume":"23","author":"CV Vorhees","year":"1994","unstructured":"Vorhees, C. V., Acuff-Smith, K. D., Schilling, M. A., Fisher, J. E., Moran, M. S., & Buelke-Sam, J. (1994). A developmental neurotoxicity evaluation of the effects of prenatal exposure to fluoxetine in rats. Fundamental and Applied Toxicology, 23, 194\u2013205.","journal-title":"Fundamental and Applied Toxicology"},{"key":"5_CR63","doi-asserted-by":"publisher","first-page":"f2059","DOI":"10.1136\/bmj.f2059","volume":"346","author":"D Rai","year":"2013","unstructured":"Rai, D., Lee, B. K., Dalman, C., Golding, J., Lewis, G., & Magnusson, C. (2013). Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: Population based case-control study. BMJ, 346, f2059.","journal-title":"BMJ"},{"key":"5_CR64","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1001\/archgenpsychiatry.2011.73","volume":"68","author":"LA Croen","year":"2011","unstructured":"Croen, L. A., Grether, J. K., Yoshida, C. K., Odouli, R., & Hendrick, V. (2011). Antidepressant use during pregnancy and childhood autism spectrum disorders. Archives of General Psychiatry, 68, 1104\u20131112.","journal-title":"Archives of General Psychiatry"},{"key":"5_CR65","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2147\/CLEP.S53009","volume":"5","author":"MJ Sorensen","year":"2013","unstructured":"Sorensen, M. J., Gronborg, T. K., Christensen, J., Parner, E. T., Vestergaard, M., Schendel, D., et al. (2013). Antidepressant exposure in pregnancy and risk of autism spectrum disorders. Clinical Epidemiology, 5, 449\u2013459.","journal-title":"Clinical Epidemiology"},{"key":"5_CR66","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s40263-016-0338-3","volume":"30","author":"S Alwan","year":"2016","unstructured":"Alwan, S., Friedman, J. M., & Chambers, C. (2016). Safety of selective serotonin reuptake inhibitors in pregnancy: A review of current evidence. CNS Drugs, 30, 499\u2013515.","journal-title":"CNS Drugs"},{"key":"5_CR67","doi-asserted-by":"publisher","first-page":"e152","DOI":"10.4088\/JCP.16f10637","volume":"77","author":"C Andrade","year":"2016","unstructured":"Andrade, C. (2016). Use of acetaminophen (paracetamol) during pregnancy and the risk of autism spectrum disorder in the offspring. The Journal of Clinical Psychiatry, 77, e152\u2013e154.","journal-title":"The Journal of Clinical Psychiatry"},{"key":"5_CR68","first-page":"309","volume":"11","author":"A Steel","year":"2015","unstructured":"Steel, A., Adams, J., Sibbritt, D., & Broom, A. (2015). The outcomes of complementary and alternative medicine use among pregnant and birthing women: Current trends and future directions. Women\u2019s Health, 11, 309\u2013323.","journal-title":"Women\u2019s Health"},{"key":"5_CR69","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1208\/s12248-013-9538-7","volume":"16","author":"Y Li","year":"2013","unstructured":"Li, Y., Saldanha, S. N., & Tollefsbol, T. O. (2013). Impact of epigenetic dietary compounds on transgenerational prevention of human diseases. The AAPS Journal, 16, 27\u201336.","journal-title":"The AAPS Journal"},{"key":"5_CR70","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1017\/S2040174417000733","volume":"8","author":"T Bianco-Miotto","year":"2017","unstructured":"Bianco-Miotto, T., Craig, J. M., Gasser, Y. P., Van Dijk, S. J., & Ozanne, S. E. (2017). Epigenetics and DOHaD: From basics to birth and beyond. Journal of Developmental Origins of Health and Disease, 8, 513\u2013519.","journal-title":"Journal of Developmental Origins of Health and Disease"},{"key":"5_CR71","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1096\/fasebj.12.11.949","volume":"12","author":"GL Wolff","year":"1998","unstructured":"Wolff, G. L., Kodell, R. L., Moore, S. R., & Cooney, C. A. (1998). Maternal epigenetics and methyl supplements affect agouti gene expression in Avy\/a mice. The FASEB Journal, 12, 949\u2013957.","journal-title":"The FASEB Journal"},{"key":"5_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15592294.2016.1257450","volume":"12","author":"S Pauwels","year":"2016","unstructured":"Pauwels, S., Ghosh, M., Duca, R. C., Bekaert, B., Freson, K., Huybrechts, I. A. S., et al. (2016). Dietary and supplemental maternal methyl-group donor intake and cord blood DNA methylation. Epigenetics, 12, 1\u201310.","journal-title":"Epigenetics"},{"key":"5_CR73","doi-asserted-by":"publisher","first-page":"253","DOI":"10.4161\/epi.7.3.19082","volume":"7","author":"CE Boeke","year":"2012","unstructured":"Boeke, C. E., Baccarelli, A., Kleinman, K. P., Burris, H. H., Litonjua, A. A., Rifas-Shiman, S. L., et al. (2012). Gestational intake of methyl donors and global LINE-1 DNA methylation in maternal and cord blood: Prospective results from a folate-replete population. Epigenetics, 7, 253\u2013260.","journal-title":"Epigenetics"},{"key":"5_CR74","doi-asserted-by":"crossref","first-page":"19814","DOI":"10.18632\/oncotarget.15057","volume":"8","author":"Y Zhu","year":"2017","unstructured":"Zhu, Y., Liao, X., Lu, L., Li, W., Zhang, L., Ji, C., et al. (2017). Maternal dietary zinc supplementation enhances the epigenetic-activated antioxidant ability of chick embryos from maternal normal and high temperatures. Oncotarget, 8, 19814\u201319824.","journal-title":"Oncotarget"},{"key":"5_CR75","doi-asserted-by":"publisher","first-page":"5017","DOI":"10.1007\/s12035-016-0035-8","volume":"54","author":"A Geoffroy","year":"2017","unstructured":"Geoffroy, A., Kerek, R., Pouri\u00e9, G., Helle, D., Gu\u00e9ant, J.-L., Daval, J.-L., et al. (2017). Late maternal folate supplementation rescues from methyl donor deficiency-associated brain defects by restoring let-7 and miR-34 pathways. Molecular Neurobiology, 54, 5017\u20135033.","journal-title":"Molecular Neurobiology"},{"key":"5_CR76","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s13148-016-0281-7","volume":"8","author":"SJ Dijk Van","year":"2016","unstructured":"Van Dijk, S. J., Zhou, J., Peters, T. J., Buckley, M., Sutcliffe, B., Oytam, Y., et al. (2016). Effect of prenatal DHA supplementation on the infant epigenome: Results from a randomized controlled trial. Clinical Epigenetics, 8, 114\u2013114.","journal-title":"Clinical Epigenetics"},{"key":"5_CR77","doi-asserted-by":"publisher","first-page":"503","DOI":"10.2217\/epi.11.71","volume":"3","author":"TM Hardy","year":"2011","unstructured":"Hardy, T. M., & Tollefsbol, T. O. (2011). Epigenetic diet: Impact on the epigenome and cancer. Epigenomics, 3, 503\u2013518.","journal-title":"Epigenomics"},{"key":"5_CR78","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s13148-010-0011-5","volume":"1","author":"SM Meeran","year":"2010","unstructured":"Meeran, S. M., Ahmed, A., & Tollefsbol, T. O. (2010). Epigenetic targets of bioactive dietary components for cancer prevention and therapy. Clinical Epigenetics, 1, 101\u2013116.","journal-title":"Clinical Epigenetics"},{"key":"5_CR79","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00431-009-1035-8","volume":"169","author":"JP Schuchardt","year":"2010","unstructured":"Schuchardt, J. P., Huss, M., Stauss-Grabo, M., & Hahn, A. (2010). Significance of long-chain polyunsaturated fatty acids (PUFAs) for the development and behaviour of children. European Journal of Pediatrics, 169, 149\u2013164.","journal-title":"European Journal of Pediatrics"},{"key":"5_CR80","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1152\/physiolgenomics.00061.2014","volume":"46","author":"H-S Lee","year":"2014","unstructured":"Lee, H.-S., Barraza-Villarreal, A., Biessy, C., Duarte-Salles, T., Sly, P. D., Ramakrishnan, U., et al. (2014). Dietary supplementation with polyunsaturated fatty acid during pregnancy modulates DNA methylation at IGF2\/H19 imprinted genes and growth of infants. Physiological Genomics, 46, 851\u2013857.","journal-title":"Physiological Genomics"},{"key":"5_CR81","doi-asserted-by":"publisher","first-page":"480","DOI":"10.3945\/ajcn.112.052241","volume":"98","author":"H-S Lee","year":"2013","unstructured":"Lee, H.-S., Barraza-Villarreal, A., Hernandez-Vargas, H., Sly, P. D., Biessy, C., Ramakrishnan, U., et al. (2013). Modulation of DNA methylation states and infant immune system by dietary supplementation with \u03c9-3 PUFA during pregnancy in an intervention study. The American Journal of Clinical Nutrition, 98, 480\u2013487.","journal-title":"The American Journal of Clinical Nutrition"},{"key":"5_CR82","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.biocel.2008.06.010","volume":"41","author":"BB Aggarwal","year":"2009","unstructured":"Aggarwal, B. B., & Harikumar, K. B. (2009). Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. The International Journal of Biochemistry & Cell Biology, 41, 40\u201359.","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"key":"5_CR83","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1177\/0269881116686883","volume":"31","author":"AL Lopresti","year":"2017","unstructured":"Lopresti, A. L. (2017). Curcumin for neuropsychiatric disorders: A review of in vitro, animal and human studies. Journal of Psychopharmacology, 31, 287\u2013302.","journal-title":"Journal of Psychopharmacology"},{"key":"5_CR84","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s40495-015-0018-x","volume":"1","author":"SSS Boyanapalli","year":"2015","unstructured":"Boyanapalli, S. S. S., & Kong, A.-N. T. (2015). \u201cCurcumin, the King of Spices\u201d: Epigenetic regulatory mechanisms in the prevention of cancer, neurological, and inflammatory diseases. Current Pharmacology Reports, 1, 129\u2013139.","journal-title":"Current Pharmacology Reports"},{"issue":"3","key":"5_CR85","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1002\/ptr.6257","volume":"33","author":"L-N Zhu","year":"2019","unstructured":"Zhu, L.-N., Mei, X., Zhang, Z.-G., Xie, Y.-P., & Lang, F. (2019). Curcumin intervention for cognitive function in different types of people: A systematic review and meta-analysis. Phytotherapy Research, 33(3), 524\u2013533.","journal-title":"Phytotherapy Research"},{"key":"5_CR86","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.ejmech.2018.12.016","volume":"163","author":"B Salehi","year":"2018","unstructured":"Salehi, B., Stojanovic-Radic, Z., Matejic, J., Sharifi-Rad, M., Anil Kumar, N. V., Martins, N., et al. (2018). The therapeutic potential of curcumin: A review of clinical trials. European Journal of Medicinal Chemistry, 163, 527\u2013545.","journal-title":"European Journal of Medicinal Chemistry"},{"key":"5_CR87","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1111\/j.1530-0277.2010.01282.x","volume":"34","author":"L Long","year":"2010","unstructured":"Long, L., Li, Y., Wang, Y. D., He, Q. Y., Li, M., Cai, X. D., et al. (2010). The preventive effect of oral EGCG in a Fetal Alcohol Spectrum Disorder Mouse Model. Alcoholism: Clinical and Experimental Research, 34, 1929\u20131936.","journal-title":"Alcoholism: Clinical and Experimental Research"},{"key":"5_CR88","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.neulet.2017.06.003","volume":"653","author":"S Isac","year":"2017","unstructured":"Isac, S., Panaitescu, A. M., Spataru, A., Iesanu, M., Totan, A., Udriste, A., et al. (2017). Trans-resveratrol enriched maternal diet protects the immature hippocampus from perinatal asphyxia in rats. Neuroscience Letters, 653, 308\u2013313.","journal-title":"Neuroscience Letters"},{"key":"5_CR89","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s00431-007-0437-8","volume":"166","author":"M Handel Van","year":"2007","unstructured":"Van Handel, M., Swaab, H., De Vries, L. S., & Jongmans, M. J. (2007). Long-term cognitive and behavioral consequences of neonatal encephalopathy following perinatal asphyxia: A review. European Journal of Pediatrics, 166, 645\u2013654.","journal-title":"European Journal of Pediatrics"},{"key":"5_CR90","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1053\/j.semperi.2015.08.002","volume":"39","author":"M Ayad","year":"2015","unstructured":"Ayad, M., & Costantine, M. M. (2015). Epidemiology of medications use in pregnancy. Seminars in Perinatology, 39, 508\u2013511.","journal-title":"Seminars in Perinatology"},{"key":"5_CR91","doi-asserted-by":"publisher","first-page":"605","DOI":"10.18549\/PharmPract.2015.02.605","volume":"13","author":"JF Mosley 2nd","year":"2015","unstructured":"Mosley 2nd, J. F., Smith, L. L., & Dezan, M. D. (2015). An overview of upcoming changes in pregnancy and lactation labeling information. Pharmacy Practice (Granada), 13, 605.","journal-title":"Pharmacy Practice (Granada)"},{"key":"5_CR92","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.ajog.2016.01.187","volume":"214","author":"LA Temming","year":"2016","unstructured":"Temming, L. A., Cahill, A. G., & Riley, L. E. (2016). Clinical management of medications in pregnancy and lactation. American Journal of Obstetrics and Gynecology, 214, 698\u2013702.","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"5_CR93","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-004365","volume":"4","author":"A Lupattelli","year":"2014","unstructured":"Lupattelli, A., Spigset, O., Twigg, M. J., Zagorodnikova, K., M\u00e5rdby, A. C., Moretti, M. E., et al. (2014). Medication use in pregnancy: A cross-sectional, multinational web-based study. BMJ Open, 4, e004365.","journal-title":"BMJ Open"},{"key":"5_CR94","doi-asserted-by":"publisher","first-page":"51.e1","DOI":"10.1016\/j.ajog.2011.02.029","volume":"205","author":"AA Mitchell","year":"2011","unstructured":"Mitchell, A. A., Gilboa, S. M., Werler, M. M., Kelley, K. E., Louik, C., & Hernandez-Diaz, S. (2011). Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008. American Journal of Obstetrics and Gynecology, 205, 51.e1\u201351.e8.","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"5_CR95","doi-asserted-by":"publisher","first-page":"51.e1","DOI":"10.1016\/j.ajog.2011.02.029","volume":"205","author":"AA Mitchell","year":"2011","unstructured":"Mitchell, A. A., Gilboa, S. M., Werler, M. M., Kelley, K. E., Louik, C., Hern\u00e1ndez-D\u00edaz, S., et al. (2011). Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008. American Journal of Obstetrics and Gynecology, 205, 51.e1\u201351.e518.","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"5_CR96","first-page":"465","volume":"100","author":"W Lo","year":"2002","unstructured":"Lo, W., & Friedman, J. (2002). Teratogenicity of recently introduced medications in human pregnancy. Obstetrics & Gynecology, 100, 465\u2013473.","journal-title":"Obstetrics & Gynecology"},{"key":"5_CR97","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/ajmg.c.30313","volume":"157","author":"MP Adam","year":"2011","unstructured":"Adam, M. P., Polifka, J. E., & Friedman, J. M. (2011). Evolving knowledge of the teratogenicity of medications in human pregnancy. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 157, 175\u2013182.","journal-title":"American Journal of Medical Genetics Part C: Seminars in Medical Genetics"},{"key":"5_CR98","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.midw.2010.08.007","volume":"27","author":"HG Hall","year":"2011","unstructured":"Hall, H. G., Griffiths, D. L., & Mckenna, L. G. (2011). The use of complementary and alternative medicine by pregnant women: A literature review. Midwifery, 27, 817\u2013824.","journal-title":"Midwifery"},{"key":"5_CR99","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1089\/jwh.2007.0579","volume":"17","author":"C Wade","year":"2008","unstructured":"Wade, C., Chao, M., Kronenberg, F., Cushman, L., & Kalmuss, D. (2008). Medical pluralism among American women: Results of a national survey. Journal of Women\u2019s Health (2002), 17, 829\u2013840.","journal-title":"Journal of Women\u2019s Health (2002)"},{"key":"5_CR100","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.midw.2009.05.010","volume":"27","author":"L Holst","year":"2011","unstructured":"Holst, L., Wright, D., Haavik, S., & Nordeng, H. (2011). Safety and efficacy of herbal remedies in obstetrics-review and clinical implications. Midwifery, 27, 80\u201386.","journal-title":"Midwifery"},{"key":"5_CR101","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/1471-2393-12-146","volume":"12","author":"A Steel","year":"2012","unstructured":"Steel, A., Adams, J., Sibbritt, D., Broom, A., Gallois, C., & Frawley, J. (2012). Utilisation of complementary and alternative medicine (CAM) practitioners within maternity care provision: Results from a nationally representative cohort study of 1,835 pregnant women. BMC Pregnancy and Childbirth, 12, 146.","journal-title":"BMC Pregnancy and Childbirth"},{"key":"5_CR102","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3122\/jabfm.2014.01.130167","volume":"27","author":"M Thomson","year":"2014","unstructured":"Thomson, M., Corbin, R., & Leung, L. (2014). Effects of ginger for nausea and vomiting in early pregnancy: A meta-analysis. Journal of American Board of Family Medicine, 27, 115\u2013122.","journal-title":"Journal of American Board of Family Medicine"},{"key":"5_CR103","doi-asserted-by":"publisher","first-page":"289","DOI":"10.4103\/0974-8520.153746","volume":"35","author":"M Firouzbakht","year":"2014","unstructured":"Firouzbakht, M., Nikpour, M., Jamali, B., & Omidvar, S. (2014). Comparison of ginger with vitamin B6 in relieving nausea and vomiting during pregnancy. Ayu, 35, 289\u2013293.","journal-title":"Ayu"},{"key":"5_CR105","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1089\/jwh.2013.4568","volume":"23","author":"GS Birdee","year":"2014","unstructured":"Birdee, G. S., Kemper, K. J., Rothman, R., & Gardiner, P. (2014). Use of complementary and alternative medicine during pregnancy and the postpartum period: An analysis of the National Health Interview Survey. Journal of Women\u2019s Health (2002), 23, 824\u2013829.","journal-title":"Journal of Women\u2019s Health (2002)"},{"key":"5_CR106","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/978-3-319-53889-1_4","volume":"978","author":"MT Siu","year":"2017","unstructured":"Siu, M. T., & Weksberg, R. (2017). Epigenetics of autism spectrum disorder. Advances in Experimental Medicine and Biology, 978, 63\u201390.","journal-title":"Advances in Experimental Medicine and Biology"},{"key":"5_CR107","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nrclinonc.2017.97","volume":"14","author":"S Moran","year":"2017","unstructured":"Moran, S., Martinez-Cardus, A., Boussios, S., & Esteller, M. (2017). Precision medicine based on epigenomics: The paradigm of carcinoma of unknown primary. Nature Reviews. Clinical Oncology, 14, 682\u2013694.","journal-title":"Nature Reviews. Clinical Oncology"}],"container-title":["Advances in Neurobiology","Personalized Food Intervention and Therapy for Autism Spectrum Disorder Management"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-30402-7_5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T02:18:21Z","timestamp":1614219501000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-030-30402-7_5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9783030304010","9783030304027"],"references-count":106,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-30402-7_5","relation":{},"ISSN":["2190-5215","2190-5223"],"issn-type":[{"value":"2190-5215","type":"print"},{"value":"2190-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"1 February 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}